Marketing-authorisation holder · Singapore
Bristol-Myers Squibb (Singapore) Pte. Ltd.
29 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Singapore
29 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial100mg/vial · Injection, powder, for suspension | Paclitaxel | Singapore | Authorised | 2014 |
| BARACLUDE TABLET 0.5mg0.5 mg · Tablet, film coated | Entecavir | Singapore | Authorised | 2006 |
| BARACLUDE TABLET 1mg1 mg · Tablet, film coated | Entecavir | Singapore | Authorised | 2006 |
| CAMZYOS CAPSULES 10MG10.0mg · Capsule | Mavacamten | Singapore | Authorised | 2023 |
| CAMZYOS CAPSULES 15MG15.0mg · Capsule | Mavacamten | Singapore | Authorised | 2023 |
| CAMZYOS CAPSULES 2.5MG2.5mg · Capsule | Mavacamten | Singapore | Authorised | 2023 |
| CAMZYOS CAPSULES 5MG5mg · Capsule | Mavacamten | Singapore | Authorised | 2023 |
| INREBIC CAPSULES 100 MG100 mg · Capsule | Fedratinib | Singapore | Authorised | 2022 |
| ONUREG FILM-COATED TABLETS 200 MG200.0 mg · Tablet, film coated | Azacitidine | Singapore | Authorised | 2022 |
| ONUREG FILM-COATED TABLETS 300 MG300.0 mg · Tablet, film coated | Azacitidine | Singapore | Authorised | 2022 |
| OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 10 MG/ML10mg/mL · Infusion, solution concentrate | Nivolumab | Singapore | Authorised | 2016 |
| OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG240mg per vial + 80mg per vial · Infusion, solution concentrate | Nivolumab, Relatlimab | Singapore | Authorised | 2023 |
| POMALYST CAPSULE 1MG1 mg · Capsule | Pomalidomide | Singapore | Authorised | 2014 |
| POMALYST CAPSULE 2MG2 mg · Capsule | Pomalidomide | Singapore | Authorised | 2014 |
| POMALYST CAPSULE 3MG3 mg · Capsule | Pomalidomide | Singapore | Authorised | 2014 |
| POMALYST CAPSULE 4MG4 mg · Capsule | Pomalidomide | Singapore | Authorised | 2014 |
| REBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL25 MG/vial · Injection, powder, for solution | Luspatercept | Singapore | Authorised | 2022 |
| REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL75.0 MG/vial · Injection, powder, for solution | Luspatercept | Singapore | Authorised | 2022 |
| Revlimid Capsules 10mg10.0 mg · Capsule | Lenalidomide | Singapore | Authorised | 2009 |
| Revlimid Capsules 15 mg15.0 mg · Capsule | Lenalidomide | Singapore | Authorised | 2009 |
| Revlimid Capsules 25 mg25.0 mg · Capsule | Lenalidomide | Singapore | Authorised | 2009 |
| Revlimid Capsules 5mg5.0 mg · Capsule | Lenalidomide | Singapore | Authorised | 2009 |
| REYATAZ CAPSULE 300MG300 mg · Capsule | Atazanavir | Singapore | Authorised | 2008 |
| SOTYKTU FILM-COATED TABLETS 6 MG6.00 mg · Tablet, film coated | Deucravacitinib | Singapore | Authorised | 2024 |
| SPRYCEL TABLETS 20MG20 mg · Tablet, film coated | Dasatinib | Singapore | Authorised | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 29 | 29 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.